PPD, Inc. (PPD) Income Statement Analysis

See more : AIAI Group Corporation (6557.T) Income Statement Analysis – Financial Results

Complete financial analysis of PPD, Inc. (PPD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PPD, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.

You may be interested

PPD, Inc. (PPD)

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Website: http://www.ppd.com

About PPD, Inc.

PPD, Inc. provides drug development services to the biopharmaceutical industry worldwide. The company operates through Clinical Development Services and Laboratory Services segments. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri- and post-approval, and medical communications services. The company also provides laboratory services comprising bioanalytical, biomarker, vaccine science, good manufacturing practice, and central laboratory services. It serves pharmaceutical, biotechnology, medical device, and government organizations, as well as other industry participants. The company was founded in 1985 and is headquartered in Wilmington, North Carolina.

Metric	2020	2019	2018	2017	2016
Revenue	4.68B	4.03B	3.75B	3.00B	2.68B
Cost of Revenue	2.88B	2.41B	2.27B	1.54B	1.39B
Gross Profit	1.80B	1.62B	1.47B	1.46B	1.29B
Gross Profit Ratio	38.42%	40.24%	39.32%	48.80%	48.25%
Research & Development	0.00	0.00	0.00	0.00	0.00
General & Administrative	0.00	0.00	0.00	0.00	0.00
Selling & Marketing	0.00	0.00	0.00	0.00	0.00
SG&A	0.00	0.00	0.00	0.00	0.00
Other Expenses	1.29B	1.20B	1.07B	1.20B	978.63M
Operating Expenses	1.29B	1.20B	1.07B	1.20B	978.63M
Cost & Expenses	4.17B	3.61B	3.35B	2.74B	2.37B
Interest Income	0.00	0.00	5.45M	3.55M	2.51M
Interest Expense	216.93M	311.74M	263.62M	253.89M	203.29M
Depreciation & Amortization	279.12M	264.83M	258.97M	279.07M	260.49M
EBITDA	668.54M	627.35M	666.36M	544.62M	630.92M
EBITDA Ratio	14.28%	15.56%	17.77%	18.15%	23.55%
Operating Income	509.43M	418.49M	402.24M	261.33M	314.26M
Operating Income Ratio	10.88%	10.38%	10.73%	8.71%	11.73%
Total Other Income/Expenses	-321.88M	-359.21M	-255.61M	-244.86M	-147.37M
Income Before Tax	187.55M	59.28M	146.63M	16.47M	166.89M
Income Before Tax Ratio	4.01%	1.47%	3.91%	0.55%	6.23%
Income Tax Expense	18.81M	2.96M	39.58M	-284.36M	-15.96M
Net Income	153.69M	47.82M	104.19M	296.03M	183.10M
Net Income Ratio	3.28%	1.19%	2.78%	9.86%	6.83%
EPS	0.44	0.14	0.32	0.91	0.56
EPS Diluted	0.44	0.14	0.32	0.91	0.56
Weighted Avg Shares Out	346.68M	339.43M	324.30M	325.04M	324.22M
Weighted Avg Shares Out (Dil)	346.68M	339.43M	324.30M	325.86M	324.30M

PPD Named a Leader in Digital Clinical Trial Solutions by ISG

March 17, 2021businesswire.com

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, has been recognized for industry leadership in digital and decentralized clinical trial solutions by Information Services Group (ISG), a leading global technology research and advisory firm. ISG recognized...

PPD Lights Up Headquarters Downtown for 2021 Rare Disease Day

February 26, 2021businesswire.com

--(BUSINESS WIRE)--PPD: WHAT: Rare Disease Day takes place on the last day of February because it is a month known for having a “rare” number of days. This annual event serves to raise awareness among the general public and decision-makers...

PPD, Inc. (PPD) CEO David Simmons on Q4 2020 Results - Earnings Call Transcript

February 25, 2021seekingalpha.com

PPD, Inc. (PPD) CEO David Simmons on Q4 2020 Results - Earnings Call Transcript

PPD to Present at Barclays Global Healthcare Conference

February 24, 2021businesswire.com

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, will present virtually at the Barclays Global Healthcare Conference. David Simmons, chairman and CEO, and Chris Scully, CFO, are scheduled to participate in a fireside chat on Tuesday,...

PPD, Inc. (PPD) Tops Q4 Earnings and Revenue Estimates

February 23, 2021zacks.com

PPD, Inc. (PPD) delivered earnings and revenue surprises of 11.43% and 6.39%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

PPD Reports Fourth Quarter and Full Year 2020 Results

February 23, 2021businesswire.com

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD Reports Fourth Quarter and Full Year 2020 Results

PPD Reports Fourth Quarter and Full Year 2020 Results

February 23, 2021businesswire.com

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, today reported its financial results for the fourth quarter and full year ended December 31, 2020. Highlights Fourth quarter net authorizations of $1,297.6 million, representing 28.1% growth and...

PPD Awarded US Army Study to Help Develop Post-Traumatic Stress Disorder Drugs

February 18, 2021businesswire.com

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, has been awarded Defense Health Agency funds to support a five-year Research Project Award (RPA) to develop and execute an adaptive platform clinical research trial of drug interventions...

PPD Honored for Employee Development Programs that Deliver Results for Customers

February 17, 2021businesswire.com

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD, Inc. (Nasdaq: PPD) has been recognized for the 10th consecutive year as one of the leading U.S. businesses for employee learning and development. PPD was named to Training magazine’s Top 100 list, which honors companies that demonstrate...